TagsAfrica Agriculture Antibiotics Antivirals Bacteria Bacteriophages Biofilms Biology Biotechnology blog cancer disease Drugs Education Emerging disease Environment Food Fungi Genetics Google+ Health History HIV/AIDS Immunology infection Influenza Malaria Medicine Microbiology Mycology Parasitology plants Podcast Prions retrovirus RNA Science Tuberculosis University of Leicester Vaccines viaGoogle+ Video Virology virus
Top Posts & Pages
This is a personal weblog. The opinions expressed here represent my own views and not those of my employer or any other organization. Comments on posts represent the opinions of visitors.
MicrobiologyBytes by AJ Cann is licensed under a Creative Commons Attribution-ShareAlike 3.0 Unported License.
Human hepatitis B virus (HBV) is the prototype of a family of small DNA viruses that productively infect hepatocytes, the major cell of the liver, and replicate by reverse transcription of a terminally redundant viral RNA, the pregenome. Upon infection, the circular, partially double-stranded virion DNA is converted in the nucleus to a covalently closed circular DNA (cccDNA) that assembles into a minichromosome, the template for viral mRNA synthesis. Infection of hepatocytes is non-cytopathic. Infection of the liver may be either transient (<6 months) or chronic and lifelong, depending on the ability of the host immune response to clear the infection. Chronic infections can cause immune-mediated liver damage progressing to cirrhosis and hepatocellular carcinoma (HCC). The mechanisms of carcinogenesis are unclear. Antiviral therapies with nucleoside analog inhibitors of viral DNA synthesis delay sequelae, but cannot cure HBV infections due to the persistence of cccDNA in hepatocytes.
Most yeast prions (infectious proteins) are amyloids, linear β-sheet-rich polymers of a single protein with the β-strands perpendicular to the long axis of the filament. A single prion protein can form any of many different prion variants, differing in structure and biological properties, but with the same amino acid sequence. The folded parallel β-sheet architecture shown for several yeast prions explains how a given prion variant can be propagated stably, how a protein can template its conformation, just as DNA can template its sequence.
A recent paper in PLoS Pathogens describes an anti-prion system that sequesters prion seeds, preventing their even distribution to daughter cells. The recent discovery of a cellular anti-prion system that cures most arising prions of the yeast Ure2 protein offers a possible direction to look for treatments of amyloidoses such as Alzheimer disease, Parkinson disease, and others. While an array of methods have been found to cure yeast prions by over- or underproduction of various chaperones and other proteins and by various conditions, the system described in this paper cures the [URE3] prion at normal expression levels, indicating that this is a cellular anti-prion system. Information gleaned from yeast systems may have applications in efforts to control human prions and amyloidoses.
Approximately 10.8% of human cancers are associated with infection by an oncogenic virus. These viruses include human papillomavirus (HPV), Epstein–Barr virus (EBV), Merkel cell polyomavirus (MCV), human T-cell leukemia virus 1 (HTLV-1), Kaposi’s sarcoma-associated herpesvirus (KSHV), hepatitis C virus (HCV) and hepatitis B virus (HBV). These oncogenic viruses, with the exception of HCV, require the host RNA splicing machinery in order to exercise their oncogenic activities, a strategy that allows the viruses to efficiently export and stabilize viral RNA and to produce spliced RNA isoforms from a bicistronic or polycistronic RNA transcript for efficient protein translation. Infection with a tumor virus affects the expression of host genes, including host RNA splicing factors, which play a key role in regulating viral RNA splicing of oncogene transcripts. A current prospective focus is to explore how alternative RNA splicing and the expression of viral oncogenes take place in a cell- or tissue-specific manner in virus-induced human carcinogenesis.
The genus Morbillivirus belongs to the virus family Paramyxoviridae, a group of enveloped viruses with non-segmented, negative strand RNA genomes. It contains viruses that are highly infectious, spread via the respiratory route, cause profound immune suppression, and have a propensity to cause large outbreaks associated with high morbidity and mortality in previously unexposed populations. In populations with endemic virus circulation, the epidemiology changes to that of a childhood disease, as hosts that survive the infection normally develop lifelong immunity.
Research on morbillivirus infections has led to exciting developments in recent years. Global measles vaccination coverage has increased, resulting in a significant reduction in measles mortality. In 2011 rinderpest virus was declared globally eradicated – only the second virus to be eradicated by targeted vaccination. Identification of new cellular receptors and implementation of recombinant viruses expressing fluorescent proteins in a range of model systems have provided fundamental new insights into the pathogenesis of morbilliviruses, and their interactions with the host immune system. Nevertheless, both new and well-studied morbilliviruses are associated with significant disease in wildlife and domestic animals. This illustrates the need for robust surveillance and a strategic focus on barriers that restrict cross-species transmission. Recent and ongoing measles outbreaks also demonstrate that maintenance of high vaccination coverage for these highly infectious agents is critical. This article summarizes the most important current research topics in this field.
The identification of cellular receptors and improvement of animal models has provided important new insights into the pathogenesis of morbillivirus infections. It has become clear that all morbilliviruses initially infect cells of the immune system, before they spread to epithelial, endothelial and/or neuronal cells. Morbilliviruses remain a potential cause of disease outbreaks in previously unexposed populations. However, they can also be used to our advantage, as vaccine vectors or as oncolytic viruses. Sustained vaccination coverage and surveillance of circulating morbilliviruses will remain of critical importance for years to come.
- Part 1: Filters and Discovery
- Part 2: The Ultracentrifuge, Eggs and Flu
- Part 3: Phages, Cell Culture and Polio
- Part 4: RNA Genomes and Modern Virology
This review discusses the structural and mechanistic basis of innate immune antagonism by two direct effectors, the Rotavirus NSP1 and VP3 proteins. It starts with a nice overview of Rotavirus biology then goes on to describe how the structural and mechanistic properties of NSP1 and VP3 allow these proteins to directly antagonize host innate immune responses.
NSP1 is a putative E3 ubiquitin ligase that mediates the degradation of a wide range of cellular targets, including those that function as innate immune sensors (RIG-I), signaling intermediates (TRAF2, MAVS, and β-TrCP), transcription factors (IRFs), and mediators of host survival pathways (PI3K and p53). In many respects, VP3 is like two proteins in one: it caps viral transcripts as they emerge from RV DLPs, which likely prevents activation of host RNA sensors, and it directly antagonizes the dsRNA-responsive OAS/RNase L pathway by cleaving the signaling molecule 2-5A. VP3 may also function in two distinct regions of the cell during infection: within a viral particle as the capping enzyme and perhaps also within the cytoplasm as a direct innate immune antagonist.
The varied functions of NSP1 and VP3 highlight the diversity and importance of cellular innate immune defenses to RNA viruses and reflect the compactness of a viral genome.
Silencing the alarms: Innate immune antagonism by rotavirus NSP1 and VP3. Virology. 24 Feb 2015 doi: 10.1016/j.virol.2015.01.006
TThe innate immune response involves a broad array of pathogen sensors that stimulate the production of interferons (IFNs) to induce an antiviral state. Rotavirus, a significant cause of childhood gastroenteritis and a member of the Reoviridae family of segmented, double-stranded RNA viruses, encodes at least two direct antagonists of host innate immunity: NSP1 and VP3. NSP1, a putative E3 ubiquitin ligase, mediates the degradation of cellular factors involved in both IFN induction and downstream signaling. VP3, the viral capping enzyme, utilizes a 2H-phosphodiesterase domain to prevent activation of the cellular oligoadenylate synthase (OAS)/RNase L pathway. Computational, molecular, and biochemical studies have provided key insights into the structural and mechanistic basis of innate immune antagonism by NSP1 and VP3 of group A rotaviruses (RVA). Future studies with non-RVA isolates will be essential to understand how other rotavirus species evade host innate immune responses.
Why does the immune system fail to clear some virus (and other infections) and allow a state of chronic infection to occur? And when it does, how are immune responses different from a non-infected individual? This article describes the processes involved in T cell exhaustion and considers what can be done to reconstitute the immune system in chronic infections, including HIV.
T cell exhaustion during persistent viral infections. (2015) Virology. 22 Jan. doi: 10.1016/j.virol.2014.12.033
Although robust and highly effective anti-viral T cells contribute to the clearance of many acute infections, viral persistence is associated with the development of functionally inferior, exhausted, T cell responses. Exhaustion develops in a step-wise and progressive manner, ranges in severity, and can culminate in the deletion of the anti-viral T cells. This disarming of the response is consequential as it compromises viral control and potentially serves to dampen immune-mediated damage. Exhausted T cells are unable to elaborate typical anti-viral effector functions. They are characterized by the sustained upregulation of inhibitory receptors and display a gene expression profile that distinguishes them from prototypic effector and memory T cell populations. In this review we discuss the properties of exhausted T cells; the virological and immunological conditions that favor their development; the cellular and molecular signals that sustain the exhausted state; and strategies for preventing and reversing exhaustion to favor viral control.
In 1915 Frederick Twort made the first scientific observations on bacteriophages (followed shortly after by Félix d’Herelle). In the century that has followed, phage research has revolutionized our understanding of biology.
“[the] molecular biology of higher organisms does not stand on the shoulder of giants, but on the shoulder of dwarfs like phage T4 and lambda.”
Phage and other viruses outnumber all other organic entities on our planet, with an estimated numbers at a mind-boggling 1031. To celebrate 100 years of phage research, a conference was held in San Diego in January and all the contributions were captured on the 2015 year of the Phage website. This includes a 400 page book which describes in detail 30 diverse phages, including, where on Earth they’ve been found, who their close relatives are, how their genomes are structured, and how they trick their hosts into submission. Researchers who have devoted their lives to phage also recount their experiences. You can download a free copy of the book from the website, and it’s well worth reading.